Metagenomic Sequencing Market Overview
Metagenomics sequencing, also known as environmental or community genomics is an approach that allows insight to be gained into community biodiversity and function. In the process of metagenomics sequencing, the DNA of the specified host microorganism is extracted and cloned directly from the microorganism using genetic analyses of DNA. The function of metagenomic sequencing market application which is to sequence the genomes of untargeted cells in a community in order to elucidate community composition and function helps to understand the several types of cells in a community and what organisms are present in their physiology.
Market Research Future (MRFR) in their recently published report on the metagenomic sequence market, declared that the market could expect 6.5% CAGR during the forecast period (2017-2023). The metagenomic sequence is sampling of genomes which helps in the study of microbial communities with a broad range of applications, right from healthcare to energy. The sampling ensures that the prior isolation and cultivation of species do not take place and maintain a natural habitat. The market is gaining much from the latest technologies that are getting implemented, such as the shotgun method and high-through-put sequencing. MRFR in their report on the metagenomic sequence market takes a peek into the drivers that can significantly impact the market. At the same time, a detailed discussion of the segments can provide greater insight about the upcoming market.
Moreover, increasing RD activities to identify new antibiotics and enzymes, and improved bioinformatics support market growth, offering some attractive opportunities to the key market players.Conversely, factors such as the rising concerns related to the standardization and accuracy of diagnostic testing alongside the lack of skilled professionals and knowledge are expected to impede the market growth over the forecast period. Nevertheless, public and private funding programs that are rapidly increasing are expected to support the market growth providing sufficient funds for RD 16s metagenomic sequencing.
Global Metagenomic sequencing Market Segmentation
MRFR report reveals the global metagenomic sequencing market as segmented by technology, application, and end-user.
- Based on the technology, the global metagenomic sequencing market can be segmented into sequencing, bioinformatics, and others. Bioinformatics is gaining much traction owing to the need for sampling of the microbial communities that were not recorded while trying the traditional modules.
- Based on the application, the global metagenomic sequencing market comprises gut microbe characterization, infectious disease diagnosis, environmental remediation, biotechnology, biofuel, ecology, agriculture, and others. Biofuel segment is gaining mileage as demand for reducing fossil fuel is getting stronger.
- Based on the end-user, the metagenomic sequencing market can be segmented into hospitals, research institutes, specialized clinics, and others.
Metagenomic sequencing Market Regional Analysis
The North American region leads the global metagenomic sequencing market owing to the presence of global players who are focused on introducing the procedures with innovative technology. Encouraging governmental support for RD activities in healthcare and metagenomic sequencing tests is acting as a significant tailwind that is pushing up the market.
Additional factors encouraging the growth of the market include increased uptake of advanced technologies in the next generation sequencing procedures and its increasing applications and high healthcare expenditures.
The metagenomic sequencing market in the US backed the increasing demand for metagenomic sequencing, contributes to the growth of the regional market majorly. Heading with the rising demands for metagenomic sequencing procedures, the region will create a larger revenue pocket in the global metagenomic sequencing market by 2023.
Metagenomic sequencing Market Key Players:
Players leading the global metagenomic sequencing market include Enterome Bioscience (France), GATC Biotech AG (Germany), Aperiomics, Inc. (U.S.), Illumina Inc. (U.S.), The Mitre Corporation (U.S.), F Hoffman-La Roche Ltd. (Switzerland), Second Genome Therapeutics (U.S.), SciGenom Labs Pvt. Ltd. (India), Quest Diagnostics Incorporated (U.S.), GenapSys, Inc. (U.S.), Freenome Inc. (U.S.), COSMOSID (U.S.), Beijing Genomics Institute (China), Pacific Biosciences (U.S.), Biomatters Ltd. (New Zealand), Oxford Nanopore Technologies Inc. (UK), Thermo Fisher Scientific Inc. (U.S.), CLC Bio (Qiagen) (Denmark), DNAStar Inc. (U.S.), Agilent Technologies Inc. (U.S.), Macrogen Inc. (South Korea), Knome Inc. (U.S.), and Helicos BioSciences (U.S.) among others.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: info@marketresearchfuture.com
0
